The following table presents restructuring costs by segment as included within the Company’s consolidated statements of operations for the periods reported (in millions):


	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Cost of revenues:
BSI BioSpin	$	0.7		$	0.2		$	2.2		$	1.2
BSI CALID		(0.5	)		0.6			(0.8	)		1.8
BSI NANO		0.1			3.6			8.4			4.0
Total Cost of revenues	$	0.3		$	4.4		$	9.8		$	7.0
Other charges, net:
BSI BioSpin	$	0.5		$	(2.5	)	$	3.4		$	3.3
BSI CALID		2.1			2.2			3.6			3.2
BSI NANO		0.3			2.0			4.0			2.8
Corporate		1.0			1.2			1.2			1.2
Total Other charges, net	$	3.9		$	2.9		$	12.2		$	10.5
Total	$	4.2		$	7.3		$	22.0		$	17.5

The following table sets forth the changes in restructuring reserves, excluding costs of $7.7 million for scrapping expired, or expiring inventory, for the six months ended June 30, 2026 (in millions):


	Total			Severance			Exit Costs
Balance at December 31, 2025	$	32.2		$	31.9		$	0.3
Restructuring charges		14.3			12.0			2.3
Cash payments		(23.9	)		(22.2	)		(1.7	)
Other, non-cash adjustments and foreign currency effect		(1.0	)		(0.8	)		(0.2	)
Balance at June 30, 2026	$	21.6		$	20.9		$	0.7

Corporate-wide Restructuring Plan: In the second quarter of 2025, the Company initiated a corporate-wide restructuring plan to be implemented across multiple functions and geographies to address macroeconomic conditions, challenges and uncertainties, drive cost efficiencies and margin improvements, as well as to better align the Company’s product offerings (the “Corporate-wide Restructuring Plan”). The Corporate-wide Restructuring Plan includes a reduction in headcount, consolidation of leased facilities, and discontinuation of certain product offerings. The Corporate-wide Restructuring Plan was completed during the second quarter of 2026, and no further costs are expected to be incurred in connection therewith.

The following table summarizes the charges incurred in connection with the corporate-wide restructuring plan by reportable segment for the periods presented (amounts in millions):


	Three Months Ended June 30,					Six Months Ended June 30,
	2026			2025		2026			2025
BSI BioSpin
Severance and termination charges	$	—		$	0.6	$	2.1		$	0.6
Inventory product restructuring charges		—			—		0.8			—
Other restructuring charges		—			—		0.1			—
Total BSI BioSpin	$	—		$	0.6	$	3.0		$	0.6
BSI CALID
Severance and termination charges	$	1.0		$	1.0	$	3.0		$	1.0
Inventory product restructuring charges		(0.5	)		—		(1.4	)		—
Other restructuring charges		0.2			—		0.2			—
Total BSI CALID	$	0.7		$	1.0	$	1.8		$	1.0
BSI NANO
Severance and termination charges	$	(0.5	)	$	2.0	$	(0.6	)	$	2.0
Inventory product restructuring charges		0.2			—		0.2			—
Other restructuring charges		0.1			—		0.1			—
Total BSI NANO	$	(0.2	)	$	2.0	$	(0.3	)	$	2.0
Corporate
Severance and termination charges	$	0.6		$	1.1	$	0.8		$	1.1
Other restructuring charges		0.3			0.1		0.4			0.1
Total Corporate	$	0.9		$	1.2	$	1.2		$	1.2
Total Corporate wide restructuring charges (a)	$	1.4		$	4.8	$	5.7		$	4.8

(a)

The Company made severance, exit, and other restructuring payments of $7.6 million and $19.5 million for the three and six months ended June 30, 2026, respectively.

BSI NANO Restructuring Plan: In the first quarter of 2026, the Company initiated a restructuring plan to be implemented in the BSI NANO segment to drive cost efficiencies and margin improvements primarily through the consolidation of certain divisions (the “BSI NANO Restructuring Plan”). The BSI NANO Restructuring Plan includes a reduction in headcount, merger of divisions within the segment, consolidation of leased facilities, and discontinuation of certain product offerings. The BSI NANO Restructuring Plan is expected to be completed during 2026.

As of June 30, 2026, the Company expects to incur minimal additional restructuring charges in connection with the BSI NANO Restructuring Plan through the remainder of 2026. However, there may be additional costs to those known as of June 30, 2026, that will be recognized through the remainder of 2026.

In connection with the BSI NANO Restructuring Plan, the BSI NANO segment deemed certain right of use (“ROU”) assets, fixed assets, and existing technology and related patents intangible assets’ fair value to be lower than its carrying value. As a result, the segment recorded impairment charges totaling $2.1 million for ROU assets, and $0.3 million for fixed assets during the three months ended June 30, 2026, and impairment charges totaling $5.2 million for ROU assets, $9.0 million for fixed assets, and $0.7 million for existing technology and related patents intangible assets during the six months ended June 30, 2026.

BSI Biosystems Restructuring Plan: Subsequent to June 30, 2026, the Company reorganized its reportable segments, refer to Note 1, Description of Business, for further information on this reorganization. In connection with this reorganization, the Company is implementing certain restructuring actions (the “BSI Biosystems Restructuring Plan”), some of which were initiated during the first quarter of 2026. The Company estimates restructuring costs associated with the BSI Biosystems Restructuring Plan will range from $12.0 million to $15.0 million and will primarily be related to severance and termination charges and facility closure related costs. The BSI Biosystems Restructuring Plan is expected to be completed during 2026.

The following table summarizes the charges incurred in connection with the BSI Biosystems Restructuring Plan for the periods presented (amounts in millions):


	Three Months Ended June 30, 2026		Six Months Ended June 30, 2026
BSI BioSpin
Severance and termination charges (a)	$	0.7	$	2.0
Inventory product restructuring charges		0.5		0.5
Total BSI BioSpin	$	1.2	$	2.5
BSI CALID
Severance and termination charges	$	0.9	$	0.9
Other restructuring charges		0.1		0.1
Total BSI CALID	$	1.0	$	1.0
Total BSI Biosystems restructuring charges (b)	$	2.2	$	3.5

(a)

Costs incurred prior to the second quarter reflect service and termination charges associated with the executive separation undertaken as part of the restructuring.

(b)

The Company made severance, exit, and other restructuring payments of $0.8 million for the three and six months ended June 30, 2026.